Nephros, Inc. (NASDAQ:NEPH) Q4 2019 Results Conference Call February 27, 2020 4:30 PM ET Company Participants Kirin Smith - Investor Relations Daron Evans - President and Chief Executive Officer Andrew Astor - Chief Operating Officer and Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Howard Halpern - Taglich Brothers Michael Brick - National Securities Bob Wassermann - Benchmark Company Art Winston - Pilot Advisors Operator Good day, and welcome to the Nephros Incorporat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32288 NEPHROS, INC. (Exact name of registrant specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 1 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. (Exact name of registrant as specified in its charter) Delaware 13-3971809 (State ...

Nephros, Inc (NASDAQ:NEPH) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Kirin Smith ??? President-PCG Advisory Daron Evans ??? Chief Executive Officer Andy Astor ??? Chief Financial Officer and Chief Operating Officer Conference Call Participants Howard Halpern ??? Taglich Brothers Michael Brick ??? National Securities Art Winston ??? Pilot Advisors Operator Good afternoon, and welcome to the Nephros Second Quarter 2019 Financial Results Conference Call. All participants w ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. (Exact name of registrant as specified in its charter) DELAWARE 13-3971809 (State or ot ...

Nephros, Inc (NASDAQ:NEPH) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Group Daron Evans - Chief Executive Officer Andy Astor - Chief Operating Officer and Chief Financial Officer Conference Call Participants Howard Halpern - Taglich Brothers Art Winston - Pilot Advisors Operator Good afternoon, and welcome to the Nephros First Quarter 2019 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Af ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. (Exact name of registrant as specified in its charter) DELAWARE 13-3971809 (State or o ...

1 Nephros, Inc. OTCQB: NEPH Corporate Presentation Q1 2019 www.nephros.com Safe Harbor Statement Certain statements in this management presentation constitute "forward-looking statements". Such statements include statements regarding the efficacy and intended use of our technologies under development, the timelines and strategy for bringing such products to market and the availability of funding sources for continued development of such products and other statements that are not historical facts, including ...

Nephros, Inc. (NASDAQ:NEPH) Q4 2018 Results Conference Call March 12, 2019 10:00 AM ET Company Participants Kirin Smith - PCG Advisory Group Daron Evans - CEO Andy Astor - Chief Operational and Financial Officer Conference Call Participants Michael Motley - Private Investor Claude Wydell - Private Investor Larry Cassidy - Private Investor Operator Good afternoon and welcome to the Nephros Incorporated Fourth and Full Year 2018 Financial Results Conference Call. All participants will be in a listen-only mode ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32288 NEPHROS, INC. (Exact name of registrant specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 1 ...